| Year |
Citation |
Score |
| 2019 |
Howes MR, Perry NSL, Vásquez-Londoño C, Perry EK. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing. British Journal of Pharmacology. PMID 31650528 DOI: 10.1111/Bph.14898 |
0.332 |
|
| 2018 |
Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, Aarsland D, Ballard C. Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dementia and Geriatric Cognitive Disorders. 44: 283-293. PMID 29393203 DOI: 10.1159/000484437 |
0.358 |
|
| 2015 |
Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG. Stage-specific changes in neurogenic and glial markers in Alzheimer's disease. Biological Psychiatry. 77: 711-9. PMID 25022604 DOI: 10.1016/J.Biopsych.2014.05.021 |
0.4 |
|
| 2014 |
Mulugeta E, Vallortigara J, Francis PT, Hye A, Kalaria RN, Perry EK, Lovestone S, Ballard CG. Dynamin protein in stroke and vascular dementia. Neuroscience Letters. 563: 118-22. PMID 24486840 DOI: 10.1016/J.Neulet.2014.01.045 |
0.382 |
|
| 2013 |
Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology. 72: 53-60. PMID 23242284 DOI: 10.1097/Nen.0B013E31827C5710 |
0.405 |
|
| 2012 |
Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease. 47: 155-62. PMID 22504537 DOI: 10.1016/J.Nbd.2012.03.033 |
0.365 |
|
| 2012 |
Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG. Increased neural progenitors in individuals with cerebral small vessel disease. Neuropathology and Applied Neurobiology. 38: 344-53. PMID 21988073 DOI: 10.1111/J.1365-2990.2011.01224.X |
0.405 |
|
| 2011 |
Perry E, Howes MJR. Medicinal plants and dementia therapy: Herbal hopes for brain aging? Cns Neuroscience and Therapeutics. 17: 683-698. PMID 22070157 DOI: 10.1111/J.1755-5949.2010.00202.X |
0.368 |
|
| 2011 |
Howes MJR, Perry E. The role of phytochemicals in the treatment and prevention of dementia Drugs and Aging. 28: 439-468. PMID 21639405 DOI: 10.2165/11591310-000000000-00000 |
0.364 |
|
| 2011 |
Collerton D, Perry E. Dreaming and hallucinations - Continuity or discontinuity? Perspectives from dementia with Lewy bodies Consciousness and Cognition. 20: 1016-1020. PMID 21531149 DOI: 10.1016/J.Concog.2011.03.024 |
0.327 |
|
| 2011 |
Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 31: 158-64. PMID 21335973 DOI: 10.1159/000324438 |
0.333 |
|
| 2011 |
O'Sullivan SS, Johnson M, Williams DR, Revesz T, Holton JL, Lees AJ, Perry EK. The effect of drug treatment on neurogenesis in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 45-50. PMID 21322018 DOI: 10.1002/Mds.23340 |
0.35 |
|
| 2011 |
Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK. Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. Hippocampus. 21: 1126-36. PMID 20665591 DOI: 10.1002/Hipo.20826 |
0.345 |
|
| 2011 |
Bernstein HG, Johnson M, Perry RH, LeBeau FE, Dobrowolny H, Bogerts B, Perry EK. Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 31: 1-10. PMID 20487308 DOI: 10.1111/J.1440-1789.2010.01117.X |
0.349 |
|
| 2011 |
Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL. Increased neural progenitors in vascular dementia. Neurobiology of Aging. 32: 2152-61. PMID 20138403 DOI: 10.1016/J.Neurobiolaging.2010.01.007 |
0.309 |
|
| 2010 |
Mukaetova-Ladinska EB, Monteith R, Perry EK. Cerebrospinal fluid biomarkers for dementia with lewy bodies. International Journal of Alzheimer's Disease. 2010: 536538. PMID 21048932 DOI: 10.4061/2010/536538 |
0.377 |
|
| 2010 |
Colloby SJ, Perry EK, Pakrasi S, Pimlott SL, Wyper DJ, McKeith IG, Williams ED, O'Brien JT. Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 86-90. PMID 20094022 DOI: 10.1097/Jgp.0B013E3181B972Aa |
0.406 |
|
| 2009 |
Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG. Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Disease and Associated Disorders. 23: 295-7. PMID 19812474 DOI: 10.1097/Wad.0B013E31819C5Ef4 |
0.391 |
|
| 2009 |
Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S. Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. Journal of Neurology. 256: 717-20. PMID 19240967 DOI: 10.1007/S00415-009-5000-2 |
0.384 |
|
| 2008 |
Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and Geriatric Cognitive Disorders. 26: 330-8. PMID 18841018 DOI: 10.1159/000161058 |
0.309 |
|
| 2008 |
Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet. Neurology. 7: 812-26. PMID 18667359 DOI: 10.1016/S1474-4422(08)70169-8 |
0.363 |
|
| 2008 |
MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, Ballard C. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 869-78. PMID 18401540 DOI: 10.1007/S00702-008-0027-6 |
0.42 |
|
| 2008 |
O'Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED. Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage. 40: 1056-63. PMID 18295510 DOI: 10.1016/J.Neuroimage.2008.01.010 |
0.367 |
|
| 2008 |
Warren NM, Piggott MA, Lees AJ, Perry EK, Burn DJ. Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias. Journal of Chemical Neuroanatomy. 35: 268-74. PMID 18282687 DOI: 10.1016/J.Jchemneu.2008.01.001 |
0.353 |
|
| 2008 |
Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, Williams ED, McKeith G, O'Brien JT. The effects of donepezil on nicotinic receptor status in dementia: A 123I-5IA-85380 SPECT study Journal of Neurology, Neurosurgery and Psychiatry. 79: 485-487. DOI: 10.1136/Jnnp.2007.121780 |
0.321 |
|
| 2008 |
Warren FE, Sharp SI, Lakics V, Boess FG, Ballard CG, Ziabreva I, Perry EK, Aarsland D, Larsen J, Francis PT. P2-226: Association of proteasome subunit expression with reduced proteolytic activity in dementia with Lewy bodies and Parkinson's disease dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1301 |
0.417 |
|
| 2007 |
Francis PT, Perry EK. Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. 22: S351-7. PMID 18175396 DOI: 10.1002/Mds.21683 |
0.437 |
|
| 2007 |
Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK. Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse (New York, N.Y.). 61: 903-11. PMID 17663455 DOI: 10.1002/Syn.20441 |
0.413 |
|
| 2007 |
Perry E. Commentary: botanical potentials in Alzheimer's disease. Journal of Alternative and Complementary Medicine. 13: 345-346. PMID 17480134 DOI: 10.1089/Acm.2006.6405 |
0.388 |
|
| 2007 |
Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 231-44. PMID 16448581 DOI: 10.1017/S146114570600647X |
0.39 |
|
| 2006 |
Colloby SJ, Pakrasi S, Firbank MJ, Perry EK, Piggott MA, Owens J, Wyper DJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage. 33: 423-9. PMID 16959499 DOI: 10.1016/J.Neuroimage.2006.07.026 |
0.404 |
|
| 2006 |
Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, Ballard C. Altered neurogenesis in Alzheimer's disease Journal of Psychosomatic Research. 61: 311-316. PMID 16938507 DOI: 10.1016/J.Jpsychores.2006.07.017 |
0.416 |
|
| 2006 |
Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathologica. 111: 115-25. PMID 16468020 DOI: 10.1007/S00401-005-0003-2 |
0.421 |
|
| 2006 |
Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease. 21: 50-6. PMID 16023355 DOI: 10.1016/J.Nbd.2005.06.008 |
0.396 |
|
| 2006 |
Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of Aging. 27: 433-8. PMID 15913843 DOI: 10.1016/J.Neurobiolaging.2005.02.004 |
0.403 |
|
| 2006 |
O’Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED. P2-322: Measurement of the α4β2 nicotinic receptor in vivo in Alzheimer’s disease with 123I-5ia-85380 SPECT Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1162 |
0.335 |
|
| 2005 |
Collerton D, Perry E, McKeith I. Why people see things that are not there: A novel perception and attention deficit model for recurrent complex visual hallucinations Behavioral and Brain Sciences. 28: 737-757. PMID 16372931 DOI: 10.1017/S0140525X05000130 |
0.302 |
|
| 2005 |
Ballard CG, Perry RH, McKeith IG, Perry EK. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 20: 872-5. PMID 16116579 DOI: 10.1002/Gps.1378 |
0.325 |
|
| 2005 |
Ray MA, Graham AJ, Lee M, Perry RH, Court JA, Perry EK. Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus. Neurobiology of Disease. 19: 366-77. PMID 16023579 DOI: 10.1016/J.Nbd.2005.01.017 |
0.313 |
|
| 2005 |
Tomimoto H, Ohtani R, Ihara M, Perry EK. Absence of cholinergic deficits in "pure" vascular dementia [1] (multiple letters) Neurology. 65: 179. PMID 16009926 DOI: 10.1212/Wnl.65.1.179 |
0.403 |
|
| 2005 |
Teaktong T, Piggott MA, Mckeith IG, Perry RH, Ballard CG, Perry EK. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behavioural Brain Research. 161: 299-305. PMID 15922057 DOI: 10.1016/J.Bbr.2005.02.019 |
0.336 |
|
| 2005 |
Tasker A, Perry EK, Ballard CG. Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment. Expert Review of Neurotherapeutics. 5: 101-6. PMID 15853480 DOI: 10.1586/14737175.5.1.101 |
0.433 |
|
| 2005 |
Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E. The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dementia and Geriatric Cognitive Disorders. 19: 357-60. PMID 15802910 DOI: 10.1159/000084705 |
0.383 |
|
| 2005 |
Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain : a Journal of Neurology. 128: 239-49. PMID 15649952 DOI: 10.1093/Brain/Awh391 |
0.421 |
|
| 2005 |
Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. The Journal of Clinical Psychiatry. 66: 633-637. DOI: 10.4088/Jcp.V66N0514 |
0.395 |
|
| 2004 |
Ray M, Bohr I, McIntosh JM, Ballard C, McKeith I, Chalon S, Guilloteau D, Perry R, Perry E, Court JA, Piggott M. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. Neuroscience Letters. 372: 220-5. PMID 15542244 DOI: 10.1016/J.Neulet.2004.09.042 |
0.337 |
|
| 2004 |
Okello EJ, Savelev SU, Perry EK. In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia. Phytotherapy Research : Ptr. 18: 624-7. PMID 15476306 DOI: 10.1002/Ptr.1519 |
0.302 |
|
| 2004 |
Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. Journal of the Neurological Sciences. 225: 39-49. PMID 15465084 DOI: 10.1016/J.Jns.2004.06.015 |
0.427 |
|
| 2004 |
Teaktong T, Graham AJ, Johnson M, Court JA, Perry EK. Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study. Neuropathology and Applied Neurobiology. 30: 243-54. PMID 15175078 DOI: 10.1046/J.0305-1846.2003.00528.X |
0.323 |
|
| 2004 |
Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. The American Journal of Psychiatry. 161: 843-9. PMID 15121649 DOI: 10.1176/Appi.Ajp.161.5.843 |
0.413 |
|
| 2004 |
McKeith IG, Wesnes KA, Perry E, Ferrara R. Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders. 18: 94-100. PMID 15087584 DOI: 10.1159/000077816 |
0.318 |
|
| 2004 |
Perry EK, Perry RH. Neurochemistry of consciousness: cholinergic pathologies in the human brain. Progress in Brain Research. 145: 287-99. PMID 14650923 DOI: 10.1016/S0079-6123(03)45020-6 |
0.451 |
|
| 2004 |
Pimlott SL, Piggott M, Owens J, Greally E, Court JA, Jaros E, Perry RH, Perry EK, Wyper D. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 108-16. PMID 12955099 DOI: 10.1038/Sj.Npp.1300302 |
0.462 |
|
| 2004 |
Collerton D, Perry E. Thalamocortical dysfunction and complex visual hallucinations in brain disease – are the primary disturbances in the cerebral cortex? Behavioral and Brain Sciences. 27: 789-790. DOI: 10.1017/S0140525X04240183 |
0.325 |
|
| 2004 |
Ballard C, Perry E, Lehmann D, Wesnes K, Holmes C. Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment in dementia Neurobiology of Aging. 25. DOI: 10.1016/J.Neurobiolaging.2003.12.002 |
0.309 |
|
| 2003 |
Court JA, Perry EK. Neurotransmitter abnormalities in vascular dementia. International Psychogeriatrics / Ipa. 15: 81-7. PMID 16191222 DOI: 10.1017/S1041610203009013 |
0.361 |
|
| 2003 |
Martin-Ruiz CM, Haroutunian VH, Long P, Young AH, Davis KL, Perry EK, Court JA. Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biological Psychiatry. 54: 1222-33. PMID 14643090 DOI: 10.1016/S0006-3223(03)00348-2 |
0.341 |
|
| 2003 |
Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacology, Biochemistry, and Behavior. 75: 651-9. PMID 12895683 DOI: 10.1016/S0091-3057(03)00108-4 |
0.361 |
|
| 2003 |
Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Annals of Neurology. 54: 235-8. PMID 12891676 DOI: 10.1002/Ana.10639 |
0.396 |
|
| 2003 |
Kennedy DO, Wake G, Savelev S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1871-81. PMID 12888775 DOI: 10.1038/Sj.Npp.1300230 |
0.335 |
|
| 2003 |
Perry E, McKeith I, Ballard C. Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology. 60: 1852-1853. PMID 12796550 DOI: 10.1212/01.Wnl.0000068336.84399.9E |
0.399 |
|
| 2003 |
Piggott MA, Owens J, O'Brien J, Colloby S, Fenwick J, Wyper D, Jaros E, Johnson M, Perry RH, Perry EK. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease. Journal of Chemical Neuroanatomy. 25: 161-73. PMID 12706204 DOI: 10.1016/S0891-0618(03)00002-4 |
0.41 |
|
| 2003 |
McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. Dementia with Lewy bodies. Seminars in Clinical Neuropsychiatry. 8: 46-57. PMID 12567332 DOI: 10.1053/Scnp.2003.50006 |
0.374 |
|
| 2003 |
Teaktong T, Graham A, Court J, Perry R, Jaros E, Johnson M, Hall R, Perry E. Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes Glia. 41: 207-211. PMID 12509811 DOI: 10.1002/Glia.10132 |
0.44 |
|
| 2002 |
Piggott M, Owens J, O'Brien J, Paling S, Wyper D, Fenwick J, Johnson M, Perry R, Perry E. Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain. Journal of Chemical Neuroanatomy. 24: 211-223. PMID 12297267 DOI: 10.1016/S0891-0618(02)00066-2 |
0.324 |
|
| 2002 |
Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C. A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. Journal of Affective Disorders. 69: 219-23. PMID 12103469 DOI: 10.1016/S0165-0327(00)00375-X |
0.304 |
|
| 2002 |
Bednar I, Paterson D, Marutle A, Pham TM, Svedberg M, Hellström-Lindahl E, Mousavi M, Court J, Morris C, Perry E, Mohammed A, Zhang X, Nordberg A. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Molecular and Cellular Neurosciences. 20: 354-65. PMID 12093166 DOI: 10.1006/Mcne.2002.1112 |
0.334 |
|
| 2002 |
Lee M, Martin‐Ruiz C, Graham A, Court J, Jaros E, Perry R, Iversen P, Bauman M, Perry E. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain. 125: 1483-1495. PMID 12076999 DOI: 10.1093/Brain/Awf160 |
0.346 |
|
| 2002 |
Nordberg A, Hellström-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). Journal of Neurochemistry. 81: 655-8. PMID 12065674 DOI: 10.1046/J.1471-4159.2002.00874.X |
0.355 |
|
| 2002 |
Svedberg MM, Svensson AL, Johnson M, Lee M, Cohen O, Court J, Soreq H, Perry E, Nordberg A. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. Journal of Molecular Neuroscience : Mn. 18: 211-22. PMID 12059039 DOI: 10.1385/Jmn:18:3:211 |
0.319 |
|
| 2002 |
Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. Journal of Neurochemistry. 73: 1590-1597. PMID 10501205 DOI: 10.1046/J.1471-4159.1999.0731590.X |
0.345 |
|
| 2001 |
Court JA, Ballard CG, Piggott MA, Johnson M, O'Brien JT, Holmes C, Cairns N, Lantos P, Perry RH, Jaros E, Perry EK. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies. Pharmacology, Biochemistry, and Behavior. 70: 571-9. PMID 11796155 DOI: 10.1016/S0091-3057(01)00644-X |
0.402 |
|
| 2001 |
Perry NS, Houghton PJ, Sampson J, Theobald AE, Hart S, Lis-Balchin M, Hoult JR, Evans P, Jenner P, Milligan S, Perry EK. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease. The Journal of Pharmacy and Pharmacology. 53: 1347-56. PMID 11697542 DOI: 10.1211/0022357011777846 |
0.358 |
|
| 2001 |
Perry EK, Martin-Ruiz CM, Court JA. Nicotinic receptor subtypes in human brain related to aging and dementia. Alcohol (Fayetteville, N.Y.). 24: 63-8. PMID 11522424 DOI: 10.1016/S0741-8329(01)00130-6 |
0.465 |
|
| 2001 |
Marutle A, Zhang X, Court J, Piggott M, Johnson M, Perry R, Perry E, Nordberg A. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. Journal of Chemical Neuroanatomy. 22: 115-26. PMID 11470559 DOI: 10.1016/S0891-0618(01)00117-X |
0.33 |
|
| 2001 |
Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. The American Journal of Psychiatry. 158: 1058-66. PMID 11431227 DOI: 10.1176/Appi.Ajp.158.7.1058 |
0.392 |
|
| 2001 |
Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Novartis Foundation Symposium. 235: 49-60; discussion 60. PMID 11280033 |
0.334 |
|
| 2001 |
Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biological Psychiatry. 49: 175-184. PMID 11230868 DOI: 10.1016/S0006-3223(00)01116-1 |
0.4 |
|
| 2000 |
Court JA, Martin-Ruiz C, Graham A, Perry E. Nicotinic receptors in human brain: topography and pathology. Journal of Chemical Neuroanatomy. 20: 281-298. PMID 11207426 DOI: 10.1016/S0891-0618(00)00110-1 |
0.401 |
|
| 2000 |
Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nãsland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, et al. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. European Journal of Pharmacology. 393: 215-22. PMID 10771016 DOI: 10.1016/S0014-2999(00)00064-9 |
0.421 |
|
| 2000 |
Ballard C, Piggott M, Johnson M, Cairns N, Perry R, McKeith I, Jaros E, O'Brien J, Holmes C, Perry E. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies Annals of Neurology. 48: 868-876. DOI: 10.1002/1531-8249(200012)48:6<868::Aid-Ana7>3.0.Co;2-0 |
0.453 |
|
| 1999 |
McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology. 53: 902-5. PMID 10496243 DOI: 10.1212/Wnl.53.5.902 |
0.33 |
|
| 1999 |
Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. The Journal of Pharmacy and Pharmacology. 51: 527-34. PMID 10411211 DOI: 10.1211/0022357991772808 |
0.396 |
|
| 1999 |
Ballard C, Holmes C, McKeith I, Neill D, O'Brien J, Cairns N, Lantos P, Perry E, Ince P, Perry R. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. The American Journal of Psychiatry. 156: 1039-45. PMID 10401449 DOI: 10.1176/Ajp.156.7.1039 |
0.416 |
|
| 1999 |
Perry E, Walker M, Grace J, Perry R. Acetylcholine in mind: A neurotransmitter correlate of consciousness? Trends in Neurosciences. 22: 273-280. PMID 10354606 DOI: 10.1016/S0166-2236(98)01361-7 |
0.467 |
|
| 1999 |
Lewis R, Wake G, Court G, Court JA, Pickering AT, Kim YC, Perry EK. Non-ginsenoside nicotinic activity in ginseng species. Phytotherapy Research : Ptr. 13: 59-64. PMID 10189953 DOI: 10.1002/(Sici)1099-1573(199902)13:1<59::Aid-Ptr423>3.0.Co;2-K |
0.37 |
|
| 1999 |
Goodchild RE, Court JA, Hobson I, Piggott MA, Perry RH, Ince P, Jaros E, Perry EK. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's disease and Parkinson's disease cases Biochemical Society Transactions. 27. DOI: 10.1042/Bst027A033 |
0.382 |
|
| 1999 |
Walker MP, Ayre GA, Ashton CH, Marsh VR, Wesnes K, Perry EK, O'Brien JT, McKeith IG, Ballard CG. A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias Human Psychopharmacology. 14: 483-489. DOI: 10.1002/(Sici)1099-1077(199910)14:7<483::Aid-Hup133>3.0.Co;2-T |
0.387 |
|
| 1998 |
Perry EK, Pickering AT, Wang WW, Houghton P, Perry NS. Medicinal plants and Alzheimer's disease: Integrating ethnobotanical and contemporary scientific evidence. Journal of Alternative and Complementary Medicine (New York, N.Y.). 4: 419-28. PMID 9884179 DOI: 10.1089/Acm.1998.4.419 |
0.377 |
|
| 1998 |
Perry E, Court J, Goodchild R, Griffiths M, Jaros E, Johnson M, Lloyd S, Piggott M, Spurden D, Ballard C, McKeith I, Perry R. Clinical neurochemistry: developments in dementia research based on brain bank material Journal of Neural Transmission. 105: 915-933. PMID 9869326 DOI: 10.1007/S007020050102 |
0.455 |
|
| 1998 |
Terzano S, Court JA, Fornasari D, Griffiths M, Spurden DP, Lloyd S, Perry RH, Perry EK, Clementi F. Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Brain Research. Molecular Brain Research. 63: 72-8. PMID 9838051 DOI: 10.1016/S0169-328X(98)00260-5 |
0.42 |
|
| 1998 |
Piggott MA, Perry EK, Marshall EF, McKeith IG, Johnson M, Melrose HL, Court JA, Lloyd S, Fairbairn A, Brown A, Thompson P, Perry RH. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease. Biological Psychiatry. 44: 765-74. PMID 9798081 DOI: 10.1016/S0006-3223(98)00127-9 |
0.364 |
|
| 1998 |
Lyras L, Perry RH, Perry EK, Ince PG, Jenner A, Jenner P, Halliwell B. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. Journal of Neurochemistry. 71: 302-12. PMID 9648879 DOI: 10.1046/J.1471-4159.1998.71010302.X |
0.352 |
|
| 1998 |
Ince PG, Perry EK, Morris CM. Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathology (Zurich, Switzerland). 8: 299-324. PMID 9546289 DOI: 10.1111/J.1750-3639.1998.Tb00156.X |
0.414 |
|
| 1996 |
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47: 1113-24. PMID 8909416 DOI: 10.1212/Wnl.47.5.1113 |
0.326 |
|
| 1996 |
Mantle D, Falkous G, Ishiura S, Blanchard PJ, Perry EK. Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Clinica Chimica Acta; International Journal of Clinical Chemistry. 249: 129-39. PMID 8737597 DOI: 10.1016/0009-8981(96)06282-1 |
0.427 |
|
| 1996 |
Perry EK, Court JA, Lloyd S, Johnson M, Griffiths MH, Spurden D, Piggott MA, Turner J, Perry RH. Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe. Annals of the New York Academy of Sciences. 777: 388-92. PMID 8624118 DOI: 10.1111/J.1749-6632.1996.Tb34450.X |
0.407 |
|
| 1996 |
Perry N, Court G, Bidet N, Court J, Perry E. European herbs with cholinergic activities : Potential in dementia therapy International Journal of Geriatric Psychiatry. 11: 1063-1069. DOI: 10.1002/(Sici)1099-1166(199612)11:12<1063::Aid-Gps532>3.0.Co;2-1 |
0.375 |
|
| 1995 |
Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain and Cognition. 28: 240-58. PMID 8546852 DOI: 10.1006/Brcg.1995.1255 |
0.466 |
|
| 1995 |
Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A, Perry RH. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64: 385-95. PMID 7700528 DOI: 10.1016/0306-4522(94)00410-7 |
0.483 |
|
| 1995 |
Mantle D, Falkous G, Ishiura S, Perry RH, Perry EK. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Journal of the Neurological Sciences. 131: 65-70. PMID 7561949 DOI: 10.1016/0022-510X(95)00035-Z |
0.328 |
|
| 1994 |
Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, Honavar M, Dean A, Griffiths M, McKeith IG. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport. 5: 747-9. PMID 8018843 DOI: 10.1097/00001756-199403000-00002 |
0.434 |
|
| 1994 |
Harrington CR, Perry RH, Perry EK, Hurt J, McKeith IG, Roth M, Wischik CM. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia (Basel, Switzerland). 5: 215-28. PMID 7951676 DOI: 10.1159/000106727 |
0.307 |
|
| 1994 |
Raghavan R, Khin-Nu C, Brown AG, Day KA, Tyrer SP, Ince PG, Perry EK, Perry RH. Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). Neuroreport. 5: 1393-6. PMID 7919207 DOI: 10.1097/00001756-199406000-00026 |
0.307 |
|
| 1994 |
Levy R, Eagger S, Griffiths M, Perry E, Honavar M, Dean A, Lantos P. Lewy bodies and response to tacrine in Alzheimer's disease The Lancet. 343: 176-176. PMID 7904023 DOI: 10.1016/S0140-6736(94)90966-0 |
0.38 |
|
| 1994 |
Court JA, Perry EK, Spurden D, Lloyd S, Gillespie JI, Whiting P, Barlow R. Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (alpha 4 beta 2) transfected into mouse fibroblasts with ion channel activity. Brain Research. 667: 118-22. PMID 7534607 DOI: 10.1016/0006-8993(94)91721-3 |
0.323 |
|
| 1993 |
Perry EK, Court JA, Johnson M, Smith CJ, James V, Cheng AV, Kerwin JM, Morris CM, Piggott MA, Edwardson JA. Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus. Hippocampus. 3: 307-15. PMID 8394772 DOI: 10.1002/Hipo.450030306 |
0.354 |
|
| 1993 |
Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, Fairbairn AF, Ince PG, Morris CM, Cheng AV. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Disease and Associated Disorders. 7: 69-79. PMID 8347330 DOI: 10.1097/00002093-199307020-00002 |
0.428 |
|
| 1993 |
Kerwin JM, Morris CM, Johnson M, Perry RH, Perry EK. Hippocampal p75 nerve growth factor receptor immunoreactivity in development, normal aging and senescence. Acta Anatomica. 147: 216-22. PMID 8249566 DOI: 10.1159/000147507 |
0.35 |
|
| 1993 |
Court JA, Perry EK, Johnson M, Piggott MA, Kerwin JA, Perry RH, Ince PG. Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Brain Research. Developmental Brain Research. 74: 73-82. PMID 8104741 DOI: 10.1016/0165-3806(93)90085-O |
0.357 |
|
| 1993 |
Perry EK, Piggott MA, Court JA, Johnson M, Perry RH. Transmitters in the developing and senescent human brain. Annals of the New York Academy of Sciences. 695: 69-72. PMID 7902056 DOI: 10.1111/J.1749-6632.1993.Tb23030.X |
0.347 |
|
| 1993 |
Perry EK, Perry RH. Neurochemical pathology and therapeutic strategies in degenerative dementia International Review of Psychiatry. 5: 363-380. DOI: 10.3109/09540269309037799 |
0.42 |
|
| 1992 |
Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiology of Aging. 13: 393-400. PMID 1625768 DOI: 10.1016/0197-4580(92)90113-C |
0.394 |
|
| 1992 |
Shaw PJ, Ince PG, Johnson M, Perry EK, Candy JM. The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human brainstem in relation to motor neuron disease. Brain Research. 572: 276-80. PMID 1611523 DOI: 10.1016/0006-8993(92)90484-Q |
0.3 |
|
| 1992 |
Kerwin JM, Morris CM, Perry RH, Perry EK. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neuroscience Letters. 143: 101-4. PMID 1436650 DOI: 10.1016/0304-3940(92)90242-Y |
0.437 |
|
| 1992 |
Perry EK, Court JA, Johnson M, Piggott MA, Perry RH. Autoradiographic distribution of [3H]nicotine binding in human cortex: relative abundance in subicular complex. Journal of Chemical Neuroanatomy. 5: 399-405. PMID 1418753 DOI: 10.1016/0891-0618(92)90056-V |
0.329 |
|
| 1992 |
Piggott MA, Perry EK, Perry RH, Court JA. [3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging. Brain Research. 588: 277-86. PMID 1393579 DOI: 10.1016/0006-8993(92)91586-4 |
0.315 |
|
| 1992 |
McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychological Medicine. 22: 911-22. PMID 1362617 DOI: 10.1017/S0033291700038484 |
0.417 |
|
| 1992 |
McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Bmj. 305: 673-678. PMID 1356550 DOI: 10.1136/Bmj.305.6855.673 |
0.359 |
|
| 1992 |
Piggott MA, Perry EK, Sahgal A, Perry RH. Examination of parameters influencing [3H]MK-801 binding in postmortem human cortex. Journal of Neurochemistry. 58: 1001-8. PMID 1346624 DOI: 10.1111/J.1471-4159.1992.Tb09354.X |
0.347 |
|
| 1992 |
Perry E, Court J. Biological correlates of dementia Current Opinion in Psychiatry. 5: 554-560. DOI: 10.1097/00001504-199208000-00016 |
0.336 |
|
| 1991 |
Mantle D, Perry EK. Comparison of Ca(2+)-activated proteinase enzyme and endogenous inhibitor activity in brain tissue from normal and Alzheimer's disease cases. Journal of the Neurological Sciences. 102: 220-4. PMID 2072120 DOI: 10.1016/0022-510X(91)90072-F |
0.411 |
|
| 1991 |
Xuereb JH, Perry RH, Candy JM, Perry EK, Marshall E, Bonham JR. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. Brain : a Journal of Neurology. 114: 1363-79. PMID 2065255 DOI: 10.1093/Brain/114.3.1363 |
0.418 |
|
| 1991 |
Cheng AV, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences. 106: 50-5. PMID 1779239 DOI: 10.1016/0022-510X(91)90193-B |
0.401 |
|
| 1991 |
Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, Edwardson JA, Ince P, Blessed G, Irving D. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences. 640: 197-202. PMID 1723256 DOI: 10.1111/J.1749-6632.1991.Tb00217.X |
0.474 |
|
| 1991 |
Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations. Biological Psychiatry. 29: 357-64. PMID 1674664 DOI: 10.1016/0006-3223(91)90221-7 |
0.394 |
|
| 1990 |
Perry EK, Marshall E, Perry RH, Irving D, Smith CJ, Blessed G, Fairbairn AF. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Disease and Associated Disorders. 4: 87-95. PMID 2357341 DOI: 10.1097/00002093-199004020-00003 |
0.475 |
|
| 1990 |
Court JA, Piggott MA, Perry EK. Nicotine reduces the binding of [3H]MK-801 to brain membranes, but not via the stimulation of high-affinity nicotinic receptors. Brain Research. 524: 319-21. PMID 2292014 DOI: 10.1016/0006-8993(90)90708-J |
0.318 |
|
| 1990 |
Mantle D, Perry EK. Comparison of aminopeptidase, dipeptidyl aminopeptidase and tripeptidyl aminopeptidase activities in brain tissue from normal and Alzheimer's disease cases. Journal of the Neurological Sciences. 98: 13-20. PMID 2230828 DOI: 10.1016/0022-510X(90)90178-P |
0.424 |
|
| 1990 |
Ghanbari HA, Miller BE, Haigler HJ, Arato M, Bissette G, Davies P, Nemeroff CB, Perry EK, Perry R, Ravid R. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. Jama. 263: 2907-10. PMID 2187102 DOI: 10.1001/Jama.1990.03440210057032 |
0.427 |
|
| 1990 |
Perry EK. Nerve growth factor and the basal forebrain cholinergic system: a link in the etiopathology of neurodegenerative dementias? Alzheimer Disease and Associated Disorders. 4: 1-13. PMID 2180439 DOI: 10.1097/00002093-199040100-00001 |
0.433 |
|
| 1990 |
Perry EK, Smith CJ, Court JA, Perry RH. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 2: 149-58. PMID 2175197 |
0.315 |
|
| 1990 |
Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Advances in Neurology. 53: 35-40. PMID 2173374 |
0.318 |
|
| 1990 |
Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biological Psychiatry. 28: 603-8. PMID 2171685 DOI: 10.1016/0006-3223(90)90398-L |
0.385 |
|
| 1990 |
Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of the Neurological Sciences. 95: 119-39. PMID 2157823 DOI: 10.1016/0022-510X(90)90236-G |
0.434 |
|
| 1990 |
Perry EK, Kerwin J, Perry RH, Blessed G, Fairbairn AF. Visual hallucinations and the cholinergic system in dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 88. PMID 2154559 DOI: 10.1136/Jnnp.53.1.88 |
0.336 |
|
| 1990 |
Sahgal A, Keith AB, Lloyd S, Kerwin JM, Perry EK, Edwardson JA. Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: potentiation of disruption by scopolamine. Pharmacology, Biochemistry, and Behavior. 37: 597-605. PMID 2128756 DOI: 10.1016/0091-3057(90)90533-N |
0.311 |
|
| 1990 |
Xuereb JH, Candy JM, Perry EK, Perry RH, Marshall E, Bonham JR. Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease. Neuropathology and Applied Neurobiology. 16: 477-88. PMID 1965733 DOI: 10.1111/J.1365-2990.1990.Tb01287.X |
0.318 |
|
| 1990 |
Xuereb JH, Perry EK, Candy JM, Bonham JR, Perry RH, Marshall E. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. Journal of the Neurological Sciences. 99: 185-97. PMID 1964958 DOI: 10.1016/0022-510X(90)90155-G |
0.412 |
|
| 1990 |
Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, Perry RH. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. Journal of Neurochemistry. 55: 1454-6. PMID 1697897 DOI: 10.1111/J.1471-4159.1990.Tb03162.X |
0.44 |
|
| 1990 |
Perry EK, Kerwin J, Perry RH, Irving D, Blessed G, Fairbairn A. Cerebral Cholinergic Activity Is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy Body Type Dementia and Geriatric Cognitive Disorders. 1: 2-4. DOI: 10.1159/000107114 |
0.361 |
|
| 1990 |
Perry EK. Hypothesis linking plasticity, vulnerability and nerve growth factor to basal forebrain cholinergic neurons International Journal of Geriatric Psychiatry. 5: 223-231. DOI: 10.1002/Gps.930050404 |
0.392 |
|
| 1989 |
Mantle D, Lauffart B, Perry EK, Perry RH. Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease. Journal of the Neurological Sciences. 89: 227-34. PMID 2926450 DOI: 10.1016/0022-510X(89)90024-5 |
0.41 |
|
| 1989 |
Smith CJ, Court JA, Keith AB, Perry EK. Increases in muscarinic stimulated hydrolysis of inositol phospholipids in rat hippocampus following cholinergic deafferentation are not parallelled by alterations in cholinergic receptor density. Brain Research. 485: 317-24. PMID 2720416 DOI: 10.1016/0006-8993(89)90576-3 |
0.322 |
|
| 1989 |
Perry EK, Perry R. Amyloid and Alzheimer's disease: a question of specificity. Neurobiology of Aging. 10: 473-4; discussion 47. PMID 2682325 DOI: 10.1016/0197-4580(89)90103-6 |
0.355 |
|
| 1989 |
Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Senile dementia of Lewy body type and spectrum of Lewy body disease. Lancet. 1: 1088. PMID 2566043 DOI: 10.1016/S0140-6736(89)92492-6 |
0.356 |
|
| 1989 |
Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet. 1: 166. PMID 2563086 DOI: 10.1016/S0140-6736(89)91187-2 |
0.342 |
|
| 1989 |
Lauffart B, Smith C, Perry E, McDERMOTT J, Mantle D. Comparison of Ca 2+ -activated proteinase enzyme and inhibitor levels in cerebral cortex from normal and Alzheimer disease cases Biochemical Society Transactions. 17: 206-207. DOI: 10.1042/Bst0170206 |
0.35 |
|
| 1989 |
Smith CJ, Perry EK, Birdsall NJM. Modulatory effects of guanylylimidodiphosphate and Mg2+ on [3H]oxotremorine-M binding in normal and Alzheimer's disease parietal cortex: an index of muscarinic receptor-G-protein coupling Biochemical Society Transactions. 17: 202-203. DOI: 10.1042/Bst0170202 |
0.376 |
|
| 1988 |
Cross AJ, Slater P, Perry EK, Perry RH. An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia. Neurochemistry International. 13: 89-96. PMID 20501276 DOI: 10.1016/0197-0186(88)90107-6 |
0.321 |
|
| 1988 |
Smith CJ, Perry EK, Perry RH, Candy JM, Johnson M, Bonham JR, Dick DJ, Fairbairn A, Blessed G, Birdsall NJ. Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. Journal of Neurochemistry. 50: 847-56. PMID 3339358 DOI: 10.1111/J.1471-4159.1988.Tb02990.X |
0.464 |
|
| 1987 |
Smith CJ, Perry EK, Perry RH, Fairbairn AF, Birdsall NJ. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain--a preliminary study in Alzheimer's disease. Neuroscience Letters. 82: 227-32. PMID 3696495 DOI: 10.1016/0304-3940(87)90135-2 |
0.416 |
|
| 1987 |
Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system. Journal of Neurochemistry. 48: 1687-92. PMID 3572398 DOI: 10.1111/J.1471-4159.1987.Tb05724.X |
0.381 |
|
| 1987 |
Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. Journal of Neurology, Neurosurgery, and Psychiatry. 50: 806-9. PMID 2956364 DOI: 10.1136/Jnnp.50.6.806 |
0.437 |
|
| 1987 |
Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation. Journal of Neurology, Neurosurgery, and Psychiatry. 50: 356. PMID 2435853 DOI: 10.1136/Jnnp.50.3.356 |
0.322 |
|
| 1987 |
Cross A, Slater P, Candy J, Perry E, Perry R. Glutamate deficits in Alzheimer's disease Journal of Neurology, Neurosurgery, and Psychiatry. 50: 357-358. DOI: 10.1136/Jnnp.50.3.357 |
0.38 |
|
| 1986 |
Perry EK, Perry RH, Smith CJ, Purohit D, Bonham J, Dick DJ, Candy JM, Edwardson JA, Fairbairn A. Cholinergic receptors in cognitive disorders. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 521-7. PMID 3791066 DOI: 10.1017/S0317167100037240 |
0.459 |
|
| 1986 |
Perry EK, Smith CJ, Atack JR, Candy JM, Johnson M, Perry RH. Neocortical cholinergic enzyme and receptor activities in the human fetal brain. Journal of Neurochemistry. 47: 1262-9. PMID 3746300 DOI: 10.1111/J.1471-4159.1986.Tb00749.X |
0.378 |
|
| 1986 |
Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. Progress in Brain Research. 70: 105-32. PMID 3554348 DOI: 10.1016/S0079-6123(08)64300-9 |
0.468 |
|
| 1986 |
Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Atack JR, Perry EK, Blessed G, Fairbairn A, Edwardson JA. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. 1: 354-7. PMID 2868298 DOI: 10.1097/00002093-198701000-00047 |
0.387 |
|
| 1986 |
Taylor GR, Carter GI, Crow TJ, Johnson JA, Fairbairn AF, Perry EK, Perry RH. Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. Experimental and Molecular Pathology. 44: 111-6. PMID 2419156 DOI: 10.1016/0014-4800(86)90038-9 |
0.346 |
|
| 1986 |
Smith CJ, Perry EK, Perry RH, Johnson M, Candy J. The status of hippocampal cholinergic receptors in human cognitive disorders Biochemical Society Transactions. 14: 1162-1163. DOI: 10.1042/Bst0141162 |
0.31 |
|
| 1986 |
Perry EK, Perry RH. CNS cholinergic markers and Alzheimer's disease Neurobiology of Aging. 7: 390-391. DOI: 10.1016/0197-4580(86)90167-3 |
0.428 |
|
| 1986 |
Perry EK, Perry RH. Unfolding the nature of senile plaque amyloid Neurobiology of Aging. 7: 437-439. DOI: 10.1016/0197-4580(86)90058-8 |
0.356 |
|
| 1985 |
Candy JM, Perry EK, Perry RH, Bloxham CA, Thompson J, Johnson M, Oakley AE, Edwardson JA. Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neuroscience Letters. 61: 91-5. PMID 4080261 DOI: 10.1016/0304-3940(85)90406-9 |
0.335 |
|
| 1985 |
Atack JR, Perry EK, Perry RH, Wilson ID, Bober MJ, Blessed G, Tomlinson BE. Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type. Journal of the Neurological Sciences. 70: 1-12. PMID 4045496 DOI: 10.1016/0022-510X(85)90182-0 |
0.335 |
|
| 1985 |
Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 48: 413-21. PMID 3998751 DOI: 10.1136/Jnnp.48.5.413 |
0.471 |
|
| 1985 |
Candy JM, Gascoigne AD, Biggins JA, Smith AI, Perry RH, Perry EK, McDermott JR, Edwardson JA. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. Journal of the Neurological Sciences. 71: 315-23. PMID 2868073 DOI: 10.1016/0022-510X(85)90070-X |
0.381 |
|
| 1985 |
Perry EK, Perry RH. New insights into the nature of senile (Alzheimer-type) plaques Trends in Neurosciences. 8: 301-303. DOI: 10.1016/0166-2236(85)90107-9 |
0.389 |
|
| 1984 |
Cross AJ, Crow TJ, Johnson JA, Perry EK, Perry RH, Blessed G, Tomlinson BE. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. Journal of the Neurological Sciences. 64: 109-17. PMID 6747659 DOI: 10.1016/0022-510X(84)90029-7 |
0.41 |
|
| 1984 |
Perry EK, Perry RH, Candy JM, Fairbairn AF, Blessed G, Dick DJ, Tomlinson BE. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neuroscience Letters. 51: 353-7. PMID 6521962 DOI: 10.1016/0304-3940(84)90402-6 |
0.342 |
|
| 1984 |
Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, Blessed G, Tomlinson BE, Fairbairn AF. Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal. Journal of Neurochemistry. 42: 1402-10. PMID 6142924 DOI: 10.1111/J.1471-4159.1984.Tb02801.X |
0.4 |
|
| 1983 |
Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. Journal of the Neurological Sciences. 59: 277-89. PMID 6854353 DOI: 10.1016/0022-510X(83)90045-X |
0.433 |
|
| 1983 |
Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbairn A. Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neuroscience Letters. 40: 199-204. PMID 6633975 DOI: 10.1016/0304-3940(83)90302-6 |
0.386 |
|
| 1983 |
Biggins JA, Perry EK, McDermott JR, Smith AI, Perry RH, Edwardson JA. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. Journal of the Neurological Sciences. 58: 117-22. PMID 6405015 DOI: 10.1016/0022-510X(83)90114-4 |
0.339 |
|
| 1983 |
Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE. Monoamine metabolism in senile dementia of Alzheimer type. Journal of the Neurological Sciences. 60: 383-92. PMID 6195313 DOI: 10.1016/0022-510X(83)90149-1 |
0.369 |
|
| 1983 |
Biggins JA, Perry RH, Candy JM, Perry EK, Bloxham CA, Johnson M, Edwardson JA. Neurotensin immunoreactivity and choline acetyltransferase activity in the cerebral cortex in Parkinson's disease Regulatory Peptides. 7: 277. DOI: 10.1016/0167-0115(83)90034-4 |
0.383 |
|
| 1983 |
Atack J, Lauffart B, Mantle D, Perry E. Peptidase activities in Alzheimer's disease Regulatory Peptides. 7: 274. DOI: 10.1016/0167-0115(83)90029-0 |
0.396 |
|
| 1982 |
Arregui A, Perry EK, Rossor M, Tomlinson BE. Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. Journal of Neurochemistry. 38: 1490-2. PMID 6278093 DOI: 10.1111/J.1471-4159.1982.Tb07930.X |
0.393 |
|
| 1982 |
Perry EK, Perry RH, Tomlinson BE. The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neuroscience Letters. 29: 303-7. PMID 6212778 DOI: 10.1016/0304-3940(82)90334-2 |
0.301 |
|
| 1981 |
Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. Journal of the Neurological Sciences. 51: 279-87. PMID 7276979 DOI: 10.1016/0022-510X(81)90106-4 |
0.447 |
|
| 1981 |
Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. British Medical Journal (Clinical Research Ed.). 282: 93-4. PMID 6779929 DOI: 10.1136/Bmj.282.6258.93 |
0.379 |
|
| 1981 |
Perry RH, Dockray GJ, Dimaline R, Perry EK, Blessed G, Tomlinson BE. Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex. Journal of the Neurological Sciences. 51: 465-72. PMID 6268760 DOI: 10.1016/0022-510X(81)90123-4 |
0.369 |
|
| 1981 |
Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Arregui A. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiology of Aging. 2: 251-6. PMID 6174877 DOI: 10.1016/0197-4580(81)90032-4 |
0.437 |
|
| 1980 |
Tarbit I, Perry EK, Perry RH, Blessed G, Tomlinson BE. Hippocampal free amino acids in Alzheimer's disease. Journal of Neurochemistry. 35: 1246-9. PMID 7452316 DOI: 10.1111/J.1471-4159.1980.Tb07883.X |
0.352 |
|
| 1980 |
Richter JA, Perry EK, Tomlinson BE. Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sciences. 26: 1683-9. PMID 7392805 DOI: 10.1016/0024-3205(80)90176-9 |
0.426 |
|
| 1980 |
Perry RH, Blessed G, Perry EK, Tomlinson BE. Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. Age and Ageing. 9: 9-16. PMID 7370097 DOI: 10.1093/Ageing/9.1.9 |
0.423 |
|
| 1980 |
Perry EK. The cholinergic system in old age and Alzheimer's disease. Age and Ageing. 9: 1-8. PMID 7361631 DOI: 10.1093/Ageing/9.1.1 |
0.41 |
|
| 1980 |
Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH. Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neuroscience Letters. 18: 105-10. PMID 6133246 DOI: 10.1016/0304-3940(80)90220-7 |
0.403 |
|
| 1978 |
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal. 2: 1457-9. PMID 719462 DOI: 10.1136/Bmj.2.6150.1457 |
0.331 |
|
| 1978 |
Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathology and Applied Neurobiology. 4: 273-7. PMID 703927 DOI: 10.1111/J.1365-2990.1978.Tb00545.X |
0.453 |
|
| 1977 |
Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neuroscience Letters. 6: 85-9. PMID 19605034 DOI: 10.1016/0304-3940(77)90070-2 |
0.4 |
|
| 1977 |
Perry EK, Perry RH, Tomlinson BE. Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex. Neuroscience Letters. 4: 185-9. PMID 19604942 DOI: 10.1016/0304-3940(77)90136-7 |
0.365 |
|
| 1977 |
Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. Journal of the Neurological Sciences. 34: 247-65. PMID 144789 DOI: 10.1016/0022-510X(77)90073-9 |
0.379 |
|
| Show low-probability matches. |
